NavaDerm Partners, which is backed by BelHealth Investment Partners, has named Dr. John Murphy as CEO. Murphy is the former regional vice president and chief medical officer at Humana. NavaDerm is a Northeast-focused dermatology services company.
New York, New York – November 5, 2019 – NavaDerm Partners (“NavaDerm” or the “Company”), a Northeast-focused dermatology services company and portfolio company of BelHealth Investment Partners (“BelHealth”), a New York-based healthcare private equity firm, announced the appointment of Dr. John Murphy as Chief Executive Officer.
John Murphy, MD, MBA, CPE, has over 30 years of experience in physician services. Previously, Dr. Murphy served as Regional Vice President and Chief Medical Officer at Humana (New York) (NYSE: HUM). Prior to Humana, Dr. Murphy was Chief Executive Officer at Delaware Valley Urology, a New Jersey-based urology organization offering the full scope of urological services from thirteen offices in South Jersey. Dr. Murphy practiced Reproductive Endocrinology and Infertility for over 15 years in both academic medical centers and private practice. He received a B.A. from the University of Pennsylvania, an M.D. from Temple University School of Medicine, completed a residency in Obstetrics and Gynecology at William Beaumont Army Medical Center, and completed a fellowship in Reproductive Endocrinology at the Johns Hopkins Hospital, where he also subsequently served on the medical school faculty. Dr Murphy received an M.B.A. from The Wharton School of the University of Pennsylvania.
Dr. Murphy stated “I am proud to join NavaDerm and lead this organization through its next growth phase. The clinical excellence and individual reputations of our physician partners is second to none. What we are building at NavaDerm is unique: a physician led and focused organization, with all founders remaining Medical Directors of their individual groups, locally branded, and ownership opportunities for Associate physicians. I look forward to building upon the strong existing foundation and accelerating NavaDerm’s growth. With several new locations opening in the next two quarters and a host of talented physicians joining our platform, we are excited about the future of NavaDerm.”
Harold Blue, Managing Partner of BelHealth and Chairman of NavaDerm, added “We are thrilled to have John join our organization and lead NavaDerm’s outstanding group of physicians and dedicated staff. With over a decade of private practice experience and long tenures leading ambulatory physician groups and payor organizations, John is uniquely qualified to take NavaDerm to the next level. With many exciting growth opportunities in front of us, we look forward to John bringing the organization together and executing on our strategic plan.”
NavaDerm Partners, headquartered in New York City, is a Northeast-based dermatology management platform formed through the partnership of five dermatology groups in New York and New Jersey. Operating out of seven locations, NavaDerm’s mission is to support its outstanding 40+ board-certified dermatologists and their dedicated staffs in providing outstanding patient care. NavaDerm’s clinicians provide world-class and comprehensive services across medical, surgical and cosmetic dermatology.
About BelHealth Investment Partners
BelHealth Investment Partners, based in New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth has a unique combination of investing, executive management and entrepreneurial experience. BelHealth acquires majority positions in entrepreneur-owned companies that it believes would benefit from its extensive operating and private equity investment expertise. The firm invests across three core healthcare segments: Services, Products and Distribution. BelHealth is investing from its current $350 million fund.